Pharmaceuticals - Community Register


List of Orphan refusals for human medicinal products


Product name: Molgramostim
Active substance: Molgramostim
Indication: Treatment of cystic fibrosis
Marketing Authorisation Holder: Drugrecure Aps

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
20/07/2010 Refusal of orphan designation EMEA/OD/082/09 (2010)5064 of 16/07/2010